What is the share price of Denis Chem Lab Ltd (DENISCHEM) today?
The share price of DENISCHEM as on 21st August 2026 is ₹71.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Denis Chem Lab Ltd (DENISCHEM) share?
The past returns of Denis Chem Lab Ltd (DENISCHEM) share are- Past 1 week: 3.62%
- Past 1 month: -1.23%
- Past 3 months: 1.64%
- Past 6 months: -6.94%
- Past 1 year: -24.78%
- Past 3 years: -39.18%
- Past 5 years: 33.07%
What are the peers or stocks similar to Denis Chem Lab Ltd (DENISCHEM)?
The peers or stocks similar to Denis Chem Lab Ltd (DENISCHEM) include:What is the dividend yield % of Denis Chem Lab Ltd (DENISCHEM) share?
The current dividend yield of Denis Chem Lab Ltd (DENISCHEM) is 3.50.What is the market cap of Denis Chem Lab Ltd (DENISCHEM) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Denis Chem Lab Ltd (DENISCHEM) is ₹99.16 Cr as of 21st August 2026.What is the 52 week high and low of Denis Chem Lab Ltd (DENISCHEM) share?
The 52-week high of Denis Chem Lab Ltd (DENISCHEM) is ₹103 and the 52-week low is ₹56.10.What is the PE and PB ratio of Denis Chem Lab Ltd (DENISCHEM) stock?
The P/E (price-to-earnings) ratio of Denis Chem Lab Ltd (DENISCHEM) is 11.81. The P/B (price-to-book) ratio is 1.08.Which sector does Denis Chem Lab Ltd (DENISCHEM) belong to?
Denis Chem Lab Ltd (DENISCHEM) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Denis Chem Lab Ltd (DENISCHEM) shares?
You can directly buy Denis Chem Lab Ltd (DENISCHEM) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Denis Chem Lab Ltd
DENISCHEM Share Price
BSE₹71.500.75% (+0.53)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
DENISCHEM Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
DENISCHEM Performance & Key Metrics
DENISCHEM Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 12.43 | 1.08 | 3.50% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.41 | 5.95 | 0.50% |
DENISCHEM Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
DENISCHEM Company Profile
Denis Chem Lab Limited makes allopathic pharmaceutical preparation and uteninary preparation.
SUNPHARMA
PE Ratio
39.76
39.76
1Y Return
15.99%
15.99%
Buy Reco %
93.55
93.55
TORNTPHARM
PE Ratio
86.09
86.09
1Y Return
34.25%
34.25%
Buy Reco %
82.14
82.14
CIPLA
PE Ratio
29.83
29.83
1Y Return
10.08%
10.08%
Buy Reco %
62.86
62.86
ZYDUSLIFE
PE Ratio
22.17
22.17
1Y Return
13.61%
13.61%
Buy Reco %
57.69
57.69
LUPIN
PE Ratio
18.88
18.88
1Y Return
12.19%
12.19%
Buy Reco %
54.55
54.55
DENISCHEM Forecast
DENISCHEM Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
DENISCHEM
DENISCHEM
Income
Balance Sheet
Cash Flow
Quarterly Normal View
DENISCHEM Income Statement
DENISCHEM Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 40.45 | 41.58 | 48.40 | 43.14 | 42.56 | 43.58 | 46.82 | 45.96 | 47.29 | 44.45 | ||||||||||
Operating & Other expenses | 34.78 | 36.91 | 41.93 | 39.02 | 39.33 | 38.46 | 41.91 | 39.49 | 44.21 | 40.17 | ||||||||||
EBITDA | 5.67 | 4.67 | 6.47 | 4.12 | 3.23 | 5.12 | 4.91 | 6.47 | 3.08 | 4.28 | ||||||||||
| Depreciation/Amortization | 1.75 | 1.63 | 1.66 | 1.84 | 1.73 | 1.61 | 1.65 | 1.83 | 1.74 | 1.53 | ||||||||||
| PBIT | 3.92 | 3.04 | 4.81 | 2.28 | 1.50 | 3.51 | 3.26 | 4.64 | 1.34 | 2.75 | ||||||||||
| Interest & Other Items | 0.23 | 0.12 | 0.09 | 0.07 | 0.23 | 0.19 | 0.23 | 0.22 | 0.20 | 0.11 | ||||||||||
| PBT | 3.69 | 2.92 | 4.72 | 2.21 | 1.27 | 3.32 | 3.03 | 4.42 | 1.14 | 2.64 | ||||||||||
| Taxes & Other Items | 0.96 | 0.84 | 1.18 | 0.46 | 0.56 | 0.84 | 0.82 | 1.09 | 0.74 | 0.60 | ||||||||||
| Net Income | 2.73 | 2.08 | 3.54 | 1.75 | 0.71 | 2.48 | 2.21 | 3.33 | 0.40 | 2.04 | ||||||||||
| EPS | 1.97 | 1.50 | 2.54 | 1.27 | 0.51 | 1.78 | 1.60 | 2.39 | 0.29 | 1.47 |
DENISCHEM Company Updates
DENISCHEM Stock Peers
DENISCHEM Past Performance & Peer Comparison
DENISCHEM Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Denis Chem Lab Ltd | 11.81 | 1.08 | 3.50% |
| Sun Pharmaceutical Industries Ltd | 39.76 | 5.44 | 0.84% |
| Torrent Pharmaceuticals Ltd | 86.09 | 10.59 | 0.69% |
| Cipla Ltd | 29.83 | 3.35 | 0.91% |
DENISCHEM Stock Price Comparison
Compare DENISCHEM with any stock or ETFCompare DENISCHEM with any stock or ETF
DENISCHEM
DENISCHEM Holdings
DENISCHEM Shareholdings
DENISCHEM Promoter Holdings Trend
DENISCHEM Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
DENISCHEM Institutional Holdings Trend
DENISCHEM Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
DENISCHEM Shareholding Pattern
DENISCHEM Shareholding Pattern
DENISCHEM Shareholding History
DENISCHEM Shareholding History
Foreign Institutions
smallcases containing DENISCHEM stock
smallcases containing DENISCHEM stock
Looks like this stock is not in any smallcase yet.
DENISCHEM Events
DENISCHEM Events
DENISCHEM Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
DENISCHEM Dividend Trend
No dividend trend available
DENISCHEM Upcoming Dividends
DENISCHEM Upcoming Dividends
Cash Dividend
Ex DateEx DateSep 18, 2026
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Sep 18, 2026
DENISCHEM Past Dividends
DENISCHEM Past Dividends
Cash Dividend
Ex DateEx DateSep 19, 2025
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Sep 19, 2025
Cash Dividend
Ex DateEx DateSep 19, 2024
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Sep 19, 2024
Cash Dividend
Ex DateEx DateSep 22, 2023
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Sep 22, 2023
Cash Dividend
Ex DateEx DateSep 20, 2022
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Sep 20, 2022
Cash Dividend
Ex DateEx DateSep 20, 2021
Final
Final | Div/Share: ₹0.75
Dividend/Share
₹0.75
Ex DateEx Date
Sep 20, 2021
DENISCHEM Stock News & Opinions
DENISCHEM Stock News & Opinions
Articles & Videos
Corporate
Corporate
Denis Chem Lab Limited to review quarterly results at board meeting on August 13Denis Chem Lab Limited will hold a board meeting on August 13, 2026, to approve the unaudited financial results for the quarter ended June 30, 2026, as per Securities and Exchange Board of India regulations, and the trading window for designated persons will remain closed until 48 hours after the financial results are declared.
2 weeks agoCapital Market - Live
Corporate
Corporate
Denis Chem Lab reappoints Dr. Himanshu C. Patel as Managing Director for three yearsDenis Chem Lab Limited announced the reappointment of Dr. Himanshu C. Patel as Managing Director for a period of 3 years, effective August 1, 2026, subject to shareholder approval at the company's 45th Annual General Meeting. Dr. Patel, an industrialist with over 4 decades of experience in the medical and pharmaceutical field, holds a B.E., M.S., and Ph.D., and currently holds 2048137 equity shares in the company.
3 weeks agoCapital Market - Live
Corporate
Corporate
Denis Chem Lab re-appoints Dr. Patel as Managing Director for three years, pending approvalDenis Chem Lab Limited announced that its board has re-appointed Dr. Himanshu C. Patel as Managing Director for a three-year term effective August 1, 2026, pending shareholder approval at the company’s 45th Annual General Meeting. The board also appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for five years, commencing financial year 2026-27, also subject to shareholder approval. The company will hold its 45th AGM on September 25, 2026, via video conferencing, and has fixed September 18, 2026, as the record date for dividend eligibility.
3 weeks agoCapital Market - Live
Corporate
Corporate
Denis Chem Lab re-appoints Dr. Patel as Managing Director for three years, pending approvalDenis Chem Lab Limited announced that its board has re-appointed Dr. Himanshu C. Patel as Managing Director for a three-year term effective August 1, 2026, pending shareholder approval at the company’s 45th Annual General Meeting. The board also appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for five years, commencing financial year 2026-27, also subject to shareholder approval. The company will hold its 45th AGM on September 25, 2026, via video conferencing, and has fixed September 18, 2026, as the record date for dividend eligibility.
3 weeks agoCapital Market - Live
Corporate
Corporate
Denis Chem Lab re-appoints Dr. Patel as Managing Director for three years, pending approvalDenis Chem Lab Limited announced that its board has re-appointed Dr. Himanshu C. Patel as Managing Director for a three-year term effective August 1, 2026, pending shareholder approval at the company’s 45th Annual General Meeting. The board also appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for five years, commencing financial year 2026-27, also subject to shareholder approval. The company will hold its 45th AGM on September 25, 2026, via video conferencing, and has fixed September 18, 2026, as the record date for dividend eligibility.
3 weeks agoCapital Market - Live
Corporate
Corporate
Denis Chem Lab Limited appoints Kashyap R. Mehta & Partners as Secretarial Auditors for five yearsDenis Chem Lab Limited announced its board has appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for five years starting financial year 2026-27, and re-appointed Dr. Himanshu C. Patel as Managing Director for three years, both appointments subject to shareholder approval at the company’s 45th Annual General Meeting on September 25, 2026. The company will hold its AGM via video conferencing or other audio-visual means, with a record date of September 18, 2026, for dividend eligibility.
3 weeks agoCapital Market - Live
Corporate
Corporate
Board of Denis Chem Lab recommends final dividendDenis Chem Lab announced that the Board of Directors of the Company at its meeting held on 30 May 2026, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.
2 months agoCapital Market - Live
Earnings
Earnings
Denis Chem Lab standalone net profit declines 43.66% in the March 2026 quarterNet profit of Denis Chem Lab declined 43.66% to Rs 0.40 crore in the quarter ended March 2026 as against Rs 0.71 crore during the previous quarter ended March 2025. Sales rose 12.98% to Rs 46.75 crore in the quarter ended March 2026 as against Rs 41.38 crore during the previous quarter ended March 2025. For the full year,net profit rose 4.08% to Rs 8.41 crore in the year ended March 2026 as against Rs 8.08 crore during the previous year ended March 2025. Sales rose 4.86% to Rs 181.72 crore in the year ended March 2026 as against Rs 173.30 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales46.7541.38 13 181.72173.30 5 OPM %5.434.98 -9.719.30 - PBDT2.883.00 -4 18.7317.97 4 PBT1.141.27 -10 11.8911.11 7 NP0.400.71 -44 8.418.08 4 Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Corporate
Denis Chem Lab announces board meeting dateDenis Chem Lab will hold a meeting of the Board of Directors of the Company on 30 May 2026.
3 months agoCapital Market - Live
Earnings
Earnings
Denis Chem Lab standalone net profit rises 88.64% in the December 2025 quarterNet profit of Denis Chem Lab rose 88.64% to Rs 3.32 crore in the quarter ended December 2025 as against Rs 1.76 crore during the previous quarter ended December 2024. Sales rose 6.26% to Rs 45.52 crore in the quarter ended December 2025 as against Rs 42.84 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales45.5242.84 6 OPM %13.228.94 - PBDT6.244.06 54 PBT4.412.22 99 NP3.321.76 89 Powered by Capital Market - Live
6 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 10.86%, vs industry avg of 11.79%
Over the last 5 years, market share stayed at 0.04%
Over the last 5 years, net income has grown at a yearly rate of 30.03%, vs industry avg of 10.55%